Patents by Inventor Takayuki Ishige

Takayuki Ishige has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-YL)benzo[B]thiophene-2-Carboxamide Hydrochloride Monohydrate
    Publication number: 20190315736
    Abstract: Crystalline Forms I and II of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate and compositions, methods of manufacture and therapeutic uses thereof are described.
    Type: Application
    Filed: October 26, 2018
    Publication date: October 17, 2019
    Inventors: Patricia Oliver-Shaffer, Gideon Shapiro, Richard Chesworth, Muneki Kishida, Takayuki Ishige
  • Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-YL)benzo[B]thiophene-2-Carboxamide Hydrochloride Monohydrate
    Publication number: 20170313694
    Abstract: Crystalline Forms I and II of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate and compositions, methods of manufacture and therapeutic uses thereof are described.
    Type: Application
    Filed: December 12, 2016
    Publication date: November 2, 2017
    Inventors: Patricia Oliver-Shaffer, Gideon Shapiro, Richard Chesworth, Muneki Kishida, Takayuki Ishige
  • Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
    Patent number: 9550767
    Abstract: Crystalline Forms I and II of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate and compositions, methods of manufacture and therapeutic uses thereof are described.
    Type: Grant
    Filed: January 20, 2016
    Date of Patent: January 24, 2017
    Assignee: Forum Pharmaceuticals, Inc.
    Inventors: Patricia Oliver-Shaffer, Gideon Shapiro, Richard Chesworth, Muneki Kishida, Takayuki Ishige
  • Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-YL)benzo[B]thiophene-2-Carboxamide Hydrochloride Monohydrate
    Publication number: 20160137638
    Abstract: Crystalline Forms I and II of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate and compositions, methods of manufacture and therapeutic uses thereof are described.
    Type: Application
    Filed: January 20, 2016
    Publication date: May 19, 2016
    Inventors: Patricia Oliver-Shaffer, Gideon Shapiro, Richard Chesworth, Muneki Kishida, Takayuki Ishige
  • Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
    Patent number: 9273044
    Abstract: Crystalline Forms I and II of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate and compositions, methods of manufacture and therapeutic uses thereof are described.
    Type: Grant
    Filed: July 9, 2015
    Date of Patent: March 1, 2016
    Assignee: Forum Pharmaceuticals, Inc.
    Inventors: Patricia Oliver-Shaffer, Gideon Shapiro, Richard Chesworth, Muneki Kishida, Takayuki Ishige
  • CRYSTALLINE FORM OF (R)-7-CHLORO-N-(QUINUCLIDIN-3-YL)BENZO[B]THIOPHENE-2-CARBOXAMIDE HYDROCHLORIDE MONOHYDRATE
    Publication number: 20160009707
    Abstract: Crystalline Forms I and II of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate and compositions, methods of manufacture and therapeutic uses thereof are described.
    Type: Application
    Filed: July 9, 2015
    Publication date: January 14, 2016
    Inventors: Patricia Oliver-Shaffer, Gideon Shapiro, Richard Chesworth, Muneki Kishida, Takayuki Ishige
  • Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride
    Patent number: 9108961
    Abstract: Crystalline Forms I and II of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate and compositions, methods of manufacture and therapeutic uses thereof are described.
    Type: Grant
    Filed: February 19, 2014
    Date of Patent: August 18, 2015
    Assignee: Forum Pharmaceuticals, Inc.
    Inventors: Patricia Oliver-Shaffer, Gideon Shapiro, Richard Chesworth, Muneki Kishida, Takayuki Ishige
  • Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-YL)benzo[B]thiophene-2-Carboxamide Hydrochloride Monohydrate
    Publication number: 20140249179
    Abstract: Crystalline Forms I and II of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate and compositions, methods of manufacture and therapeutic uses thereof are described.
    Type: Application
    Filed: February 19, 2014
    Publication date: September 4, 2014
    Applicant: ENVIVO PHARMACEUTICALS, INC.
    Inventors: Patricia Oliver-Shaffer, Gideon Shapiro, Richard Chesworth, Muneki Kishida, Takayuki Ishige
  • Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
    Patent number: 8710227
    Abstract: Crystalline Forms I and II of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate and compositions, methods of manufacture and therapeutic uses thereof are described.
    Type: Grant
    Filed: May 17, 2011
    Date of Patent: April 29, 2014
    Assignee: EnVivo Pharmaceuticals, Inc.
    Inventors: Patricia Oliver-Shaffer, Gideon Shapiro, Richard Chesworth, Muneki Kishida, Takayuki Ishige
  • Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-yl)benzo[B]thiophene-2-Carboxamide Hydrochloride Monohydrate
    Publication number: 20130183380
    Abstract: Crystalline Forms I and II of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate and compositions, methods of manufacture and therapeutic uses thereof are described.
    Type: Application
    Filed: May 17, 2011
    Publication date: July 18, 2013
    Applicant: EnVivo Pharmaceuticals, Inc.
    Inventors: Patricia Oliver-Shaffer, Gideon Shapiro, Richard Chesworth, Muneki Kishida, Takayuki Ishige
  • Benzimidazole compound in crystal form and salt thereof
    Patent number: 8471032
    Abstract: The present invention aims to provide a stable form of (R)-2-{3-[1-(acenaphthen-1-yl)piperidin-4-yl]-2,3-dihydro-2-oxo-benzimidazol-1-yl}-N-methylacetamide, which is free of problems of water adsorption and the like, and shows superior water solubility. The present invention provides a crystal and a salt of (R)-2-{3-[1-(acenaphthen-1-yl)piperidin-4-yl]-2,3-dihydro-2-oxo-benzimidazol-1-yl}-N-methylacetamide in a crystal form.
    Type: Grant
    Filed: September 16, 2009
    Date of Patent: June 25, 2013
    Assignee: Mitsubishi Tanabe Pharma Corporation
    Inventors: Sumie Sekiguchi, Takayuki Ishige, Masanori Minoguchi, Hideki Horiuchi, Shinichirou Ono, Toshihiko Tanaka
  • Apparatus for removing dissolved hydrogen sulfide in anaerobic treatment
    Patent number: 8163179
    Abstract: Disclosed is an apparatus for removing dissolved hydrogen sulfide, including an anaerobic treatment tank (1) that anaerobically treats organic discharged water, a circulation water tank (3), means for introducing organic discharged water into circulation water, a treated-water tank (4) that temporarily stores anaerobically treated water, a biological desulfurization tower (5) that desulfurizes biogas formed by anaerobic treatment, air feeding means for feeding air to the biological desulfurization tower (5), water feeding means for feeding water to the biological desulfurization tower (5), first aerating means (9a) for blowing a part of biologically desulfurized gas from the biological desulfurization tower (5), into the treated-water tank (4), and second aerating means (9b) for blowing exhaust gas discharged from the treated-water tank (4) into a solution circulating between the anaerobic treatment tank (1) and circulation water tank (3).
    Type: Grant
    Filed: December 12, 2008
    Date of Patent: April 24, 2012
    Assignee: Kabushiki Kaisha Toshiba
    Inventors: Yasuhiko Nagamori, Takumi Obara, Nobuyuki Ashikaga, Hiroshi Tamura, Toshiharu Ishihara, Takayuki Ishige, Miyuki Momiji
  • BENZIMIDAZOLE COMPOUND IN CRYSTAL FORM AND SALT THEREOF
    Publication number: 20110178128
    Abstract: The present invention aims to provide a stable form of (R)-2-{3-[1-(acenaphthen-1-yl)piperidin-4-yl]-2,3-dihydro-2-oxo-benzimidazol-1-yl}-N-methylacetamide, which is free of problems of water adsorption and the like, and shows superior water solubility. The present invention provides a crystal and a salt of (R)-2-{3-[1-(acenaphthen-1-yl)piperidin-4-yl]-2,3-dihydro-2-oxo-benzimidazol-1-yl}-N-methylacetamide in a crystal form.
    Type: Application
    Filed: September 16, 2009
    Publication date: July 21, 2011
    Inventors: Sumie Sekiguchi, Takayuki Ishige, Masanori Minoguchi, Hideki Horiuchi, Shinichirou Ono, Toshihiko Tanaka
  • BIOLOGICAL DESULFURIZATION APPARATUS
    Publication number: 20100273242
    Abstract: Disclosed is a desulfurization apparatus including a biological reaction tank 1 into which a hydrogen sulfide gas-containing gas is introduced, a carrier-packed layer 2a, 2b that is arranged in the biological reaction tank 1 and packed with a carrier for adhesion of microorganisms, a means that feeds an oxygen-containing gas to the biological reaction tank 1, and two or more sprinkling mechanisms 3, 4 that sprinkle water necessary for the organisms on the upper part of the biological reaction tank 1.
    Type: Application
    Filed: December 16, 2008
    Publication date: October 28, 2010
    Inventors: Takumi Obara, Yasuhiko Nagamori, Nobuyuki Ashikaga, Hiroshi Tamura, Takayuki Ishige, Takeo Yamamori
  • BIOLOGICAL DESULFURIZATION APPARATUS
    Publication number: 20100261266
    Abstract: Disclosed is a biological desulfurization apparatus including a reaction tower 1 into which biogas generated by anaerobic fermentation of organic waste is to be introduced, a carrier-packed layer 2a, 2b arranged in the reaction tower and provided with a carrier to which microorganisms have adhered, an air feeding pipe 3 that mixes air into a lower part of the reaction tower, and a sprinkling mechanism 7 that sprinkles water on an upper part of the reaction tower, wherein the carrier-packed layer is arranged in two or more stages.
    Type: Application
    Filed: December 19, 2008
    Publication date: October 14, 2010
    Inventors: Yasuhiko Nagamori, Takumi Obara, Nobuyuki Ashikaga, Hiroshi Tamura, Takayuki Ishige, Takeo Yamamori
  • APPARATUS FOR REMOVING DISSOLVED HYDROGEN SULFIDE IN ANAEROBIC TREATMENT
    Publication number: 20100101985
    Abstract: Disclosed is an apparatus for removing dissolved hydrogen sulfide, including an anaerobic treatment tank (1) that anaerobically treats organic discharged water, a circulation water tank (3), means for introducing organic discharged water into circulation water, a treated-water tank (4) that temporarily stores anaerobically treated water, a biological desulfurization tower (5) that desulfurizes biogas formed by anaerobic treatment, air feeding means for feeding air to the biological desulfurization tower (5), water feeding means for feeding water to the biological desulfurization tower (5), first aerating means (9a) for blowing a part of biologically desulfurized gas from the biological desulfurization tower (5), into the treated-water tank (4), and second aerating means (9b) for blowing exhaust gas discharged from the treated-water tank (4) into a solution circulating between the anaerobic treatment tank (1) and circulation water tank (3).
    Type: Application
    Filed: December 12, 2008
    Publication date: April 29, 2010
    Inventors: Yasuhiko Nagamori, Takumi Obara, Nobuyuki Ashikaga, Hiroshi Tamura, Toshiharu Ishihara, Takayuki Ishige, Miyuki Momiji
  • Optically Active Tetrahydronaphthalene Derivative
    Publication number: 20080194640
    Abstract: A compound represented by the following formula (I), a pharmacologically acceptable salt thereof or a hydrate thereof or a solvate thereof, which shows not only a C5a receptor antagonistic activity but also high activity in the biological availability, as compared to its racemate.
    Type: Application
    Filed: February 7, 2006
    Publication date: August 14, 2008
    Inventors: Mitsuharu Nakamura, Seigo Ishibuchi, Tatsuyuki Ohtsuka, Hiroshi Sumichika, Sumie Sekiguchi, Takayuki Ishige, Naoko Ueda
  • Polymorph forms of N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-B]quinolin-4-YL)-2-(2-oxopyrrolidin-1-YL)acetamide
    Patent number: 6884805
    Abstract: The invention relates to novel polymorph crystal forms A and B of N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide: The compounds and pharmaceutical compositions thereof are useful for activating a malfunctioned cholinergic neuron that is associated with memory loss disturbances.
    Type: Grant
    Filed: April 19, 2002
    Date of Patent: April 26, 2005
    Assignee: Mitsubishi Pharma Corporation
    Inventors: Haruko Yamabe, Takayuki Ishige
  • Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-1yl)acetamide
    Publication number: 20040122034
    Abstract: The invention relates to novel polymorph crystal forms A and B of N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide: 1
    Type: Application
    Filed: October 17, 2003
    Publication date: June 24, 2004
    Inventors: Haruko Yamabe, Takayuki Ishige